SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-049743
Filing Date
2020-04-22
Accepted
2020-04-22 16:32:24
Documents
5
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2016187-3_defa14a.htm DEFA14A 13885
2 GRAPHIC tm2016187-3_defa14aimg001.jpg GRAPHIC 157200
3 GRAPHIC tm2016187-3_defa14aimg002.jpg GRAPHIC 239661
4 GRAPHIC tm2016187-3_defa14aimg003.jpg GRAPHIC 99047
5 GRAPHIC tm2016187-3_defa14aimg004.jpg GRAPHIC 18346
  Complete submission text file 0001104659-20-049743.txt   723816
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 20808247
SIC: 2834 Pharmaceutical Preparations